About Christine Brennan
Form D filings for Redona Therapeutics from 2022 to 2023 list Christine Brennan as director.
Christine Brennan first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Christine Brennan in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Christine Brennan works with at each company, as listed on that company's latest Form D.
Redona Therapeutics, Inc. · Form D, Jul 31, 2023
MS
Michal Silverberg
Director
KS
Kazumi Shiosaki
President and Chief Executive Officer, director
LE
Luke Evnin
Director
HR
Henrijette Richter
Director